The New PE Playbook: Dealmaking, Exits and Returns in 2026
Join our webinar as we unpack key findings from the 2026 PE Dealmaking Report, featuring PitchBook data. Our panel of private equity experts will discuss how sponsors are adapting investment, financing and exit strategies as the economics of private equity evolve.
The webinar will explore:
- How private credit is reshaping financing capacity
- Why premium assets continue to command outsized valuations
- What reopening exit markets could mean for liquidity
- How operational value creation is driving PE returns
Panelists:
- Scott Voss, Managing Director, Senior Market Strategist, HarbourVest Partners
- Marilyn Adler, Founder and Managing Partner, Mizzen Capital
- Sascha Alilovic, Managing Director, SHS Capital
Moderator:
- Stefan Rogalski, VP of Sales, SS&C Intralinks
Running time:
- 1 hour

Transcript
stefan rogalski
00:05 - 01:08
Alright. Good afternoon, good morning, and good evening for those of us located around the world.
And welcome to today's webinar, the new PE playbook, deal making exits and returns. I'm Stefan Ryalski, VP of sales at SS and C Intralinks, and I'm excited to be joined by a great panel of leaders within the private market space.
Today's discussion builds on our recently published PE deal making report produced in collaboration with, PitchBook. The report looks at some of the key trends shaping private equity from deal making and valuations to, investment, returns and exits.
We'll use the report as a starting point to dig into, what's happening across the market, how firms are navigating different aspects of the market, and where the opportunities may lie ahead. But before we dive in, like to give each of our panelists a chance to introduce themselves.
Let's go in, alphabetical order. Marilyn, why don't we start with you and then, Sasha and Scott.
Marilyn Adler
01:08 - 01:30
Great. Thank you so much for having me today.
Marilyn Adler, one of the founders of Mizzen Capital. We are focused on lending to lower middle market companies, 1 to 15,000,000 of EBITDA in manufacturing and business services.
Sascha Alilovic
01:30 - 02:08
Yeah. Good to meet you, all here in this panel.
I'm very much looking forward to the discussion. My name is Sascha Lubitsch.
I am managing partner of SHS Capital. SHS is focusing on, healthcare investments, a 100%, healthcare investments based in Europe.
We are, building European healthcare champions, from our headquarter in Chebegen, which is a town no one has ever heard of, outside of Germany, which is, basically in Oxford or Cambridge or whatever you want. Very strong in life sciences.
And, yeah. Very much looking forward to the discussion on this panel.
stefan rogalski
02:08 - 02:12
Thanks, Sasha.
Scott Voss
02:12 - 02:38
Yep. So, Scott Boss.
I'm a partner at HarborVest Partners. HarborVest is a global, private equity multi manager firm, so we give our investors access to private markets, venture capital, growth equity, leverage buyout, private credit infrastructure around the world, and we do it through three major access points, fund investments, secondary investments, as well as direct co investments.
So thank you for for having us here today.
stefan rogalski
02:38 - 04:13
Fantastic. Thanks, everyone.
Just a bit of housekeeping on my end to give everyone a sense of, what we're gonna be covering today. We're gonna start with sort of the bigger picture.
Right? What's happening across private equity and and where investors are finding opportunities. And from there, we'll get into valuations, what makes assets attractive, and where, the growing role sort of a private credit, I guess, is an understatement.
We'll also talk about, where returns are coming from today, how firms are approaching exits, and when it makes sense to sell versus hold. And finally, looking into next year, 2027 and beyond, what the market might be overlooking and how technology and AI could play a role.
So, sort of overall agenda for the audience. Feel free to submit questions through the platform along the way, and we'll try to answer them.
But we'll certainly leave, some time at the end, for q and a. So with that, let's jump into our first question, sort of looking at the state of private equity.
And one thing that stood out to me in the report was the contrast between where capital is going and where deals are actually happening. And diving right into some numbers, megadeals account for over 75 of invested capital this year, but add ons and growth investments make up roughly 77% of deal volume.
So what does this tell us about the market today? Right? Are we seeing a fundamental shift in deal making, or is this more of a a cyclical trend? Scott, let's, start with you on that one.
Scott Voss
04:13 - 05:42
Yeah. Yeah.
Thank you. You know, what's also interesting, if you look at investment activity, it's it's kind of at all time highs right now just if you look at the headline number.
If if you take out 2021, which I think was a bit of a. An an anomaly year, but I think as we all know, it costs now to borrow, and you need to build a balance sheet to buy a company, and that balance sheet includes both debt and equity.
So with the large kind of mega deals, I think there's more resources available to borrow from to build a balance sheet, and, investors can pay a good attractive price for those assets that they're acquiring. But then the second chapter of that playbook is actually to go out and do add on acquisitions at values that are accretive to the headline price that you purchased your your large platform, at.
So I think that's how the market is adapting to the reality that debt actually costs something today where it hasn't for the last fifteen years. I think there's a second component there where a lot of the deals that got done back in the '21 and '22 kind of COVID era time frame, there were high prices paid for those companies.
So sponsors are trying to kinda buy their way into those valuations through the same playbook. It's the do add on acquisitions at valuations that are accretive and bring down your average purchase price multiple.
So I think that's probably an underlying factor that's driving those ratios you just shared.
stefan rogalski
05:42 - 05:48
Interesting. Scott.
Sasha, what what are your what are your thoughts on this?
Sascha Alilovic
05:48 - 07:12
Yeah. And again, just echo what what Scott said.
I mean, you also see a lot of concentration, of the funds raised, these days in in those large cap and mega funds. Obviously those mega funds and large cap funds, need to deploy capital in a way more significant way, than than, well, in each and every single transaction.
So, getting more dry powder into those large cap, funds means automatically they're doing. There's more more deals done in the space unless they keep they keep the dry powder for too long, which is also not in the interest of the LPs.
But looking at, the high magnitude of transactions out there, obviously the vast majority of transactions are more on the, let's say, smaller areas and smaller magnitudes. I mean, just by the numbers, it's obvious that there's way more, companies between 10 and 500,000,000 of revenues than between 510,000,000,000 of revenues.
I mean, that's kind of the obvious, most obvious, observation, which by definition means there will always be in terms of volume, more small transactions and bigger transactions. And yeah, again, those add on for a number of reasons just mentioned by Scott, to the large caps to drive down and bring down the average, enterprise value paid, EBITDA model paid.
stefan rogalski
07:12 - 07:16
And, Marilyn, is a similar perspective from the capital provider's view?
Marilyn Adler
07:16 - 08:13
Yeah. We we always focus on the lower lower middle market.
So it's not really tied so much to the economy and interest rates. It could be a death in the family, a divorce, a fight with a sibling.
So these businesses are always looking to, you know, sell some equity or make an add on acquisition, and we really specialize in roll ups. So most of our companies are in that 2 to 8,000,000 of EBITDA and looking to do a buy and build and get to each, you know, could be 10,000,000, 25,000,000, different target of where they wanna grow.
But the plan is typically to get to this larger size through add on acquisitions and integration and then sell it for a larger multiple. So most of these add ons are being done in that four to six times EBITDA, and, you know, the goal, sell it to ten ten to 15 times EBITDA as you keep on growing and integrating.
Scott Voss
08:13 - 08:30
And, Marilyn, my guess is your companies that you're. you're focused on are less reliant on leverage to build the balance sheet by the company.
Right? They're probably over equitized, if you will. So interest rates are not as much of a.
Don't have as much of an impact. Right?
Marilyn Adler
08:30 - 09:11
Correct. We keep the leverage levels pretty low, like, about two and a half to three times in terms of the leverage.
And so we're expecting a lower middle market private equity fund or an independent sponsor to raise equity capital to partner with us. We are.
We're not gonna buy a company for somebody. And.
so even if, there's a lot of funds out there now that are funding, independent sponsors, these are funds set up to fund them. We still want the sponsor to have skin in the game with us and to put something.
Go raise money from family and friends. We want Thanksgiving to be awkward if the deal isn't working well.
stefan rogalski
09:11 - 09:32
Yeah. Awkward holidays.
Always fun. But, Scott, you mentioned, and bring up an interesting topic, right, with another Fed decision coming next week.
Curious, right, how much the direction of interest rates is influences. Influencing decisions? Are investors waiting for more clarity, or has the market largely adjusted?
Scott Voss
09:32 - 10:20
Personally, I I kinda feel like the market's adjusted, but the the whole. Take it away from deal doing, the interest rate discussion's interesting because if you look at growth in the economy, it's driven driven largely by AI spend, and I feel like those that are spending don't really care where interest rates are.
They're gonna spend regardless. But then there's another part of the market that's highly sensitive to interest rates.
And and so it's two different stories, playing out. But I I feel like, I I don't think we're gonna be surprised by interest rate decisions, and it's priority baked into any underwriting that's going on.
But the reality is if you bought something five years ago, you were able to pay more for it than you can pay today, and I would expect that that's gonna be the case going forward.
stefan rogalski
10:20 - 10:38
Mhmm. And, Sasha, on your end, is it.
Is there sort of a a view on on on rates next next week? Are there any sort of thoughts around, you know, if if, if there is another sort of small increase, if if that's gonna sort of affect decision making this year or into early next year?
Sascha Alilovic
10:38 - 11:16
Well, we're based in Europe. We're doing European transactions.
We're doing the small end of the market. So, we're doing also transactions.
Sweet spot is between 3 and 7,000,000 of EBITDA levels. Also low, low leverage, fast growing companies, 15, 20% top line growth, high margins.
So yeah, typically we also do two to three times, leverage, on the, on the EBITDA. So yes, for us, I would say it has very indirect consequences, what the Fed says next week in comparison to other things happening in the world.
So yeah, this is probably less, for once, less of a headache for us.
stefan rogalski
11:16 - 11:57
Sure. So let's move on.
Let's let's talk about sort of, what what firms are looking for in investment and what they're looking to pay for. Right? Another interesting finding from the report is what's happening with valuations.
Median acquisition multiples have come down, but we're still seeing high quality businesses command premium, prices. So what's actually driving that difference? What makes an asset worth paying up for today, and has, picking the right business become more important than getting the broader market timing right? Sasha, let's go back to you on that one.
Sascha Alilovic
11:57 - 13:39
Yeah. Sure.
I mean, there's no doubt that broader market timing is also essential, to, I mean, to get your average above when you get the wrong timing, obviously. But having said that, so I mean, in a rising tide, I've looked it up actually.
I have the same expression in The US than we do as we do in Germany. The rising tide lifts all boats.
We have basically the same expression. On the other hand, yes, we see quite, a volatility or quite a discrepancy between, let's say, medium quality businesses, or something you you might wanna buy versus the must have businesses.
For the must have businesses, especially in our area, in our segment, you can still see very high prices. Maybe not as high as in the past.
We have seen 25 times EBITDA multiples on on very, very aggressively growing, high margin businesses people perceive to be a must have asset for them to then grow on a global scale. This has come down, but it's still very attractive.
We're still seeing, early twenties, late teens, basically EBITDA multiples paid for those businesses. When you see a clear differentiation, a clear growth trajectory, very high gross margin, so you can.
And you can scale the business significantly. And then this is actually paid by both, strategics and PEs.
When they can see that a year from now, the EBITDA multiple paid is basically 10 x and then a year, after five x. Well, that's easy to pay up, at the outset.
stefan rogalski
13:39 - 13:46
Right. And, Scott, any any sort of thoughts on sort of the broader differences in in in valuations and asset performance?
Scott Voss
13:46 - 14:36
Yeah. You know, it's interesting.
When when we look at the market today, I think a word that gets used a lot is dispersion. And I think when you look in underlying portfolios, there is dispersion of quality of of assets.
And as Sasha alluded to, I think there was a there was a point in time where the market was lifting all boats and buyers of those assets weren't as disciplined as they needed to be. It felt like every boat looked the same.
And now that those boats sit in the portfolios, we're realizing that's not the case. And and LPs are demanding liquidity right now, and there is competitive capital out there that's looking to be deployed.
So the best assets in that portfolio have a competitive dynamic that maybe those that you would grade as b or b minus assets are not getting the same level of interest, and dispersion's showing itself right now.
stefan rogalski
14:36 - 15:13
Yeah. And finding the right asset at the right price is only one part of the equation.
The next piece is how deals get financed, and I think that's. an area where the landscape has changed quite a bit over the last number of years, and private credit has obviously become a much bigger part of the financing landscape.
But I'm curious sort of what is, making the biggest difference? Is it simply giving sponsors more financing options, or is the real value in providing more flexible structures that allow businesses to grow while managing risk? Marilyn, let me start with you on this one.
Marilyn Adler
15:13 - 16:24
So, yeah, I I think the whole. The rise in private credit is really.
Is terrific because we could be a lot more flexible and work with the companies. We provide delayed draw facilities, so you don't have to go through an underwriting every single time.
We like to see each of the deals and decide if we wanna do it. But it's not a a whole committee process where if you're working with a bank, it's, probably a lot more bureaucratic, and they also want heavy amortization.
Whereas, you know, alternative credit funds like Mizzen can be, we're not looking to have the heavy amortization. We want the companies to continue to grow and do add on acquisitions and integrate.
And so just having that flexibility, I think is really important in a lot of these add ons because they. There's a lot of them.
Like, we've done over 70 add ons with our companies. And, again, it's just a much quicker process and much more flexible in terms of getting it done quickly, monitoring it with the cash flows of the business and when they're expecting seller notes to get repaid.
And so, I think this has really changed the whole dynamic for m and a and for roll ups.
stefan rogalski
16:24 - 16:34
Before we bring in, Sasha and Scott, just out of curiosity, Marilyn, do you. Over 70 add ons, do you see sort of that that trend continuing into next year?
Marilyn Adler
16:34 - 17:18
Absolutely. We're seeing a lot of, you know, we we work a lot of smaller manufacturing companies as well as, like, a lot of the service companies, HVAC, landscape services, roofing, plumbing, pest control, and it's just very fragmented.
There's, like, 36,000,000 small businesses, about 43% of the economy. And so there's just a lot of opportunities to to go after these smaller companies where a lot of these founders don't have kids that wanna go into their business, called the silver tsunami.
So we're finding that they. These these roll ups are really a way for them to exit.
And so I I think the the trend is just gonna continue.
stefan rogalski
17:18 - 17:24
Yep. Scott, any any.
Interested to hear your view on this as well.
Scott Voss
17:24 - 17:32
Well, here's the irony. I.
When I retire, these are the businesses that I think I'm gonna go into because I know I I have somebody that's gonna buy me out at the back end.
Marilyn Adler
17:32 - 17:33
Call. me.
Scott Voss
17:33 - 18:54
Private credit private credit's fascinating. You know, it's an asset class that really didn't exist fifteen years ago.
It came into being because of the financial crisis. The traditional lenders, the banks were the ones that financed the the leveraged buyouts.
And and today, 80% of these, especially the small mid market, is financed by private credit. And it's really critical infrastructure for our industry to function the right way because as as Marilyn alluded to, every transaction is kind of a.
It's a bespoke negotiated deal where the terms apply to the deal. It's not a boilerplate term sheet.
And there's actually somebody who's sitting on a. On the other side of the table of the equity sponsor, so it's not a big syndicated group where you don't know who's in charge.
That that being said, as an allocator, you know, private credit has an advantage because it's less regulated than the traditional lenders. But as an allocator, you rely on self regulation from those that you're giving capital to, and you have to kinda trust that they're gonna make thoughtful, informed, and and proper underwriting decisions.
And, I think as we've seen as private credit has entered the headlines, it's not this, like, broad contagion. It's actually pockets of risk that are idiosyncratic depending on the behavior of the.
Those that are underwriting the deals.
stefan rogalski
18:54 - 19:00
Yeah. Sasha, are you seeing, curious to hear your views, what you're seeing across Europe?
Sascha Alilovic
19:00 - 20:22
Yeah. What we certainly see is, we're very much in favor and and very thankful also for, private credit, being helpful in transactions for us.
I mean, as I alluded upon, is. I mean, we are investing into fast growing companies, so typically those.
But small. So typically they are still very much dependent and driven by the founder owners and maybe a small team, at the very top.
And, for them, it's super important to be flexible, and to understand well that they have a partner also on the debt side, which, understands their business basically a bit better, maybe, as well, and and is also more interested in the final outcome than, amortization, in between. And also covenants are usually a bit a bit less restrictive.
Obviously, it comes at a price. You're going to pay up a bit, in comparison, but looking at the amount of headache that you can reduce on the management teams, having to take consideration all the consequences of, I don't know, whatever investments done, add ons, what have you, that is usually very much worth the difference in the pricing.
So we we like to work with, with, our product creditors.
stefan rogalski
20:22 - 20:53
Yeah. Let's let's dive a little deeper into this.
Right? Historically, you know, leverage and multiple expansion, operational improvements, they have all played a role in in driving returns. But curious, how that mix is changing.
Are we seeing more emphasis on on, you know, growing the underlying business and improving operations? And, you know, further, you know, what do you think really moves the needle when it comes to generating strong returns today and into next year? Sasha, I wanna go back to you on that one.
Sascha Alilovic
20:53 - 22:30
Well, yeah. Sure.
I'm a bit biased, because, I mean, we we we, historically, we didn't use any, any leverage whatsoever of very, very limited leverage. And we just started to use leverage because it would be a bit, well, non intelligent, to not, using it for the companies that have grown a bit.
I mean, now we're looking at a company with 30,000,000, €30 of EBITDA, and no debt whatsoever. It probably makes sense to to take some leverage here as well for transaction.
But, yeah. I mean, looking at how you can really differentiate yourself, and how you can create value, I think it's very obvious it's going to be, mostly operational.
It's going to be, AI initiatives, that executed in the typical medium sized companies and let's say, run-in a bit more traditional way, so to speak, where you have lots of efficiency gains on one hand, but also the potential to support your, your sales organizations in a very effective way, which is not necessarily rolled out and used as today. And then also, especially for the smaller companies operating in a larger market, that they can address.
Yeah, obviously it's operational, value created by by growing those businesses significantly. That's at least our playbook.
And leverage, I mean, ads, spicing still, and some bit sugaring, icing on the cake, but it's it's definitely not, a major element in our in our in our value creation methodology.
stefan rogalski
22:30 - 22:36
Yeah. Marilyn, how do you think about sort of sustainable performance from a credit perspective?
Marilyn Adler
22:36 - 23:28
We are looking for recurring revenue and strong EBITDA. Really, that.
That's the most important to us. And a lot of times we are looking.
We like the operational efficiencies. But, you know, some of the companies have a ton of add backs and it's like we wanna see over time those dissipate and be able to show that the company can perform on its own and that these acquisitions were accretive to, to the company.
So we'll. We we dig in our diligence.
We're really looking at that. Is that revenue consistent? Can you count on it? What.
How diversified are the customers, the jobs? And just wanna make sure these are need to have products and services, not nice to have. So really trying to, you know, look at what would someone pay for in a downturn and make sure that that's really where we're focused.
stefan rogalski
23:28 - 23:39
Yeah. And, Scott, how.
You know, looking at sort of connecting this to broader market, return expectations and and different market dynamics, interested to hear your take on that.
Scott Voss
23:39 - 25:14
Yeah. I would just agree with the other speakers.
I think first of all, you can't buy a GDP grower, lever it up and make a private equity return anymore. You have to buy something that's growing above the market rate, that.
Whose business model has durability. You know, I think AI was briefly referenced, but it's interesting how it cuts across different portfolios.
You know, software companies for twenty years were able to kinda live on 80% gross margins. Like, how that could happen without somebody ever disrupting them is is unbelievable to me, but now it's it's getting disrupted.
But on the other side of the equation, you know, basic industry companies that have lived off one or 2% net margins are now able to use AI to make them more operationally efficient and turn those companies to five or 10% net margins, which is which is equally compelling. I I think the thing that's showing up in our portfolio now that's really interesting is how certain kinda mature organizations, especially in technology, are almost building a parallel kinda capability that's completely AI enabled that runs alongside the original business.
Ultimately, they probably either converge or they, the the AI business actually obsoletes the old business, but that's kinda how you have to kinda manage around this new world that we're in that is. Where AI is affecting all different parts of the portfolio in in different ways.
Again, it's this idiosyncratic. It's not just one big story.
It's it's multiple stories when you look through at the underlying assets.
stefan rogalski
25:14 - 25:44
Yeah. Yeah.
There's certainly, you know, obviously, a lot of emphasis today on finding resilient businesses and also, managing, you know, that downside risk. Can, you know, can that focus sometimes go too far? Right? Is there a risk that as investors come.
Become, you know, perhaps so selective that you actually miss attractive opportunities? And how do you sort of strike the balance between protecting capital and and pursuing growth? Marilyn, let's go back to you on that.
Marilyn Adler
25:44 - 26:35
was gonna say I'm a lender, so I'm always looking at the downside. So it's, for us, it's like, is this.
Does this make sense? You know, if the company that's trying to make a geographic expansion or it's another type of service company that's expanding to provide. If it's a roofing company wanting to expand into HVAC, we just have to make sure it makes sense because, again, we're really focused on the downside.
We get small equity co invest or warrants on some of our deals because we're really. Like, 70% of our deals are direct with owner managed companies, not with private equity funds.
And so, again, we're really focused on protecting our capital on the downside. So there are times that we might not be as looking as upside as Scott and Sasha, but, again, we wanna make sure our our debt gets repaid.
stefan rogalski
26:35 - 26:45
Yeah. Well, let's go to Sasha.
I mean, you know, perspective on investing for growth and value creation sort of. How do you how do you think about that?
Sascha Alilovic
26:45 - 28:20
Yeah. I think what.
What's what's definitely true is for us at least, we are also trying to listen. Well, I mean, in the past, we've been trying to be disciplined, as was, elaborating upon.
I mean, there was a time when basically everything, especially in all our space, med tech, pharma suppliers, and so on, everything was shiny, and everything was going through the roof. Also in terms of pricing, we have been tried.
We have tried to, to stay disciplined. And now we are trying to not overlook opportunities which are maybe not so much flavor of the day, which are maybe, a bit less less fashionable because of, political changes, a bit less, let's say, latest news on specific, either compound classes.
I mean, in pharma, for example, compound classes or, in med tech, on, on, on different, different aspects of the same. Medical device regulations and so on.
But trying to basically think of what's going to happen in the next five to ten years, because also has to be important and interesting for the next acquirer. And where is the gap? Maybe also for the strategics, the large strategics, we're buying 50% of our portfolio companies.
And then staying disciplined, on the pricing. That is what what we believe is going to generate, the value for us.
So, yes, we'll still probably overlook some some some of the more exciting areas, which maybe are perceived to be exciting already, and therefore people have to pay up to get it.
stefan rogalski
28:20 - 28:20
Yeah.
Sascha Alilovic
28:20 - 28:30
Yeah. On the other hand, overlooking things that are maybe a bit, out of fashion is is hopefully not something that will happen to us too often.
stefan rogalski
28:30 - 29:19
Yeah. Yeah.
Finding opportunities, managing risk, creating value, all important aspects. But, let's move on to the other side of the equation.
Right? How and when firms actually realize that value. One thing that's interesting about exit markets is that activity can look very different depending on the type of business sector or, market segment you're looking at.
And I might actually bring in, one of the q and a questions that popped up already. But, what are you seeing, where are you seeing the most activity and opportunities for exits today, and sort of what's separating the businesses that are attracting buyers from those that aren't? And how do you see this evolving over the next, call it, twelve months or so? Scott, let's start with you.
Scott Voss
29:19 - 29:33
Yep. Absolutely.
And and, Sasha, maybe just to connect the dots here, the strategic acquirers of your portfolio companies, are they European? Are they global? What are they. Is there a way to generalize, or are they all all things above?
Sascha Alilovic
29:33 - 30:12
Yeah. Well, they're global with a focus on US buyers.
So I would say Chinese buyers are also becoming more and more. Well, I mean, that's maybe going in cycles, I would say.
US buyers are always at the top of the list. And then there's European buyers as well, but.
So in general, it's global, but yes, US buyers is a typical example of buyers for our companies where we develop them in Europe. And so The US market, they can see it becoming, globally, available, and and demanded looked after products with high margins, and then they can buy it, plug it into their sales forces, and really generate synergies, all of this.
Scott Voss
30:12 - 32:12
Yep. Okay.
Yeah. So so on the liquidity question, we're in general.
It's another thing where I think you have to look past the benchmark or the index and start dissecting it because there's dispersion within that story as well. You know, we talked about the large scale deals.
I think there is concentration, not only deals getting done at the high end, but also in exits, being achieved. You know, the most obvious is is a company like SpaceX where it goes public and raises $86,000,000,000 and buys x a.
AI for $250,000,000,000 and buys Cursor for $60,000,000,000. There's a lot of concentration in that SpaceX trade.
And if you're a venture investor, it's like, were you in those deals or not, and when did you get into them? Because if you're in them or not, it changes what your portfolio looks like relative to the benchmark. I I do think those that own more traditional, mature assets, are selling to strategics who now have time to actually do their work, and and they're they're strong buyers because of the synergies that they realize in the acquisition.
And they don't necessarily have private equity beating them to the the trade, so they can they can kinda spend the time that they need to to make sure that the the acquisition's a good one and the integration makes sense. And then obviously, the the secondary market has stepped in to be a bit of a release valve when there's no liquidity window at all.
And and I think what's interesting around secondary is it used to be very concentrated in just the traditional PE trade, and now it's diversified or stratified. You have private credit secondaries, you have venture secondaries, you have single asset versus LP, kind of diversified portfolios.
And that's become, I think, a really important part of the market given the. Just the dispersion and the liquidity story more broadly across portfolios.
stefan rogalski
32:12 - 32:16
Marilyn, how are you thinking about the secondaries market? Sorry. Go ahead.
Marilyn Adler
32:16 - 32:29
No. I was gonna ask if Scott and Sasha are seeing much longer holding periods because it used to be, like, a four year hold period, five year max, and now it seems like it's even longer than that.
Scott Voss
32:29 - 33:26
Yeah. It's it's definitely extending, a year or two, maybe even three years.
And part of that are the deals that got done in in 2021. If if you bought it.
I don't. I I get criticized for saying this.
I don't think there was a good deal that was done in 2021. It doesn't matter how great the company was.
You probably pay too high a price. And, and and now the owners of those companies, they they might still own good companies, but they gotta grow into that valuation.
And they're not gonna hit their three to four x return target over three to four years. It could be five or six years before they get to a a return target that may not even be what they originally underwrote, but is.
That is satisfactory for a private equity investment. So maybe it's a a two x return threshold before you actually go back back to market.
But that. I think that's a big contributor to the the elongated hold periods just because the entry price was too high.
Right?
Sascha Alilovic
33:26 - 35:27
Yeah. And maybe just adding to this, I mean, and and, it's actually artificially it's to some extent also artificially shown to be less than it really in reality is if you're looking, at the CVs, right? I mean, a CV is basically keeping on to the business for longer and, maybe predominantly it's new LPs.
So for for for the LPs actually are able to sell the business or to sell their to sell their their investment into that business. They get liquidity.
On the other hand, there's a reason why there's a CV. And, so people basically and GPs, hold longer to those assets if they believe they are of high quality than they used to.
Instead of instead of, selling them at at, the higher price, and then invest into the next generation of investments. So, but, yes, we also see longer holding periods.
We see, we also have done investments in the twenty twenty twenty, '21, '22, periods. I'm not going to, well, or maybe I would contradict because we have done some really nice returns on those.
But, but I mean, obviously, we might've been very lucky. We might've been very disciplined, whatever happened.
But but for for some of those transactions, they have been really, really good, and have exited in the meantime as well. But having said that, yes.
I mean, it was so easy in comparison to sell a business, at a high EBITDA multiple, in '21, 2020, '22. And whoever bought into at the time and paid up, it's tough to get to a decent money multiple with those ones.
Absolutely. I mean, not only operational, you have to you have to improve, significantly, but you also have to fight basically against the, EBITDA multiple deterioration.
So, yeah, there's there's a lot of things to to cope with. Yeah.
So fully agree on the holding periods.
Scott Voss
35:27 - 36:17
I I think what's interesting about the CV, it used to be ten years ago if TPG sold the KKR, it was called the secondary. Right? It was private equity buying from private equity.
Now it's TPG doing a CV and bringing in a secondary buyer. But the thing that needs to be considered there is private equity is both economic interest in a private company, but also in some cases, the promise of value add.
And if if you're not selling your portfolio company, the scarce resource is the value add. You're not freeing yourself up to actually go work on other companies.
Right? And, I think it'll be interesting to see how the industry evolves to to deal with that. I.
I'm curious if some secondary buyers actually build value added capability and it starts to look more like, that traditional old school secondary that we talked about. So.
Sascha Alilovic
36:17 - 37:08
Yeah. You also maybe just say to this because I think it's an interesting point.
Some of those CVs, especially for for small cap, and low middle market PE firms, they have done quite sizable, quite sizable CVs. And then the question is, what's the.
And all doing it from the same team. Right? So, the question probably is, what is the focus of the team? Right? If you look at a very significant CV, which is maybe the size size or maybe even larger than the size of the funds they've just raised, what is going to happen if that CV is is not going well? Everyone is going to put their full attention and focus on the CV, unless someone else can convince me on the opposite.
But, I would be. Yeah.
It's. I'm always a bit, interested how that really works out in everyday's life, for for for those GPs.
Yeah.
Marilyn Adler
37:08 - 37:13
So neither one of you have done these these CVs?
Sascha Alilovic
37:13 - 37:15
We we haven't done? this to me. Yeah.
Scott Voss
37:15 - 37:15
Yeah.
Sascha Alilovic
37:15 - 37:17
No.
Scott Voss
37:17 - 37:59
So so we live on both sides of them. Our secondary practice is a leader in doing the CVs, but in the original fund investments that we make, we actually sell into these CVs or roll into the CVs.
So we see it from all sides. And I I think Sasha's right.
Like, one of the questions I asked or I see a couple weeks ago is, like, let's look at the individual's economic impact based on if they didn't do the CB and they just held it versus rolling all of their carry into this new CB. Now what what does it mean for the individual, from an economic standpoint? And and I think Sasha's right.
Like, there there are implications there that probably need to be considered.
stefan rogalski
37:59 - 38:48
Yeah. We discussed a lot, and we have, just a quick reminder.
If you're in the audience, feel free to submit those questions. We see a bunch coming in, which we'll get to the next few minutes.
But before we do, wanna sort of bring everything we discussed together and and look a bit ahead into next year. Talked about sort of, you know, separating the winners versus the losers into next year.
And, will it come back, come down to, finding better deals, right, maybe deals more attractive or less expensive than they were in 2021, structuring capital more creatively, or is it, executing more effectively during ownership, and knowing sort of when to pick your pick your spot to exit? Scott, let's go back to you on this.
Scott Voss
38:48 - 40:33
Yeah. This is an interesting question because it it is probably one of the more the more complicated moments that we've all had to live through and invest into.
And it kinda just brings you back to first principles and investing. And and part of that is when it's complicated like this and you don't know where interest rates are going or you don't know what the next geopolitical event's gonna be, the best thing you can do is get your asset allocation right, be diversified, invest in ideas that are non correlated.
So diversification just doesn't mean more things. It means invest in things that are non correlated that will probably be impacted in different ways depending on what the next uncertain event is that happens.
But where you can really move the needle and where it. It's the the has versus the have nots or the winners versus non winners is that the underwriting of the individual asset and and getting that right within a nice broadly diversified investment policy.
And that's kind of the approach that we've taken. An example venture is all the rage right now and we'll see how long that continues its marks, it's not always exits.
But certain pension funds in The US are being scrutinized because they're underperforming a benchmark, but one of the reasons they might be underperforming is because they didn't have venture in their allocation. And so that's just a portfolio corruption decision, not necessarily a bad kind of investment decision.
So I think, you know, those are our principles. It's investment policy needs to be long term right.
Diversification is critical, but make sure you get your. You're partnered with the right managers or you're underwriting really good assets at the right valuations.
stefan rogalski
40:33 - 40:38
Yeah. Let's go around the horn.
Sasha, what are your thoughts?
Sascha Alilovic
40:38 - 42:51
Well, I mean, nothing to contradict, to Scott's Scott's, statements. I mean, obviously, we are very much focused on one industry, healthcare.
We are very much focused on one geography, well, Europe, and then especially the DACH region. So the German speaking countries, which is a very big region within Europe for pharmatic and pharma suppliers, the biggest by far.
Well, for us, it's important when we look at the prospective portfolio companies that we have the chance to basically avoid a single geography risk, with those companies. So any any, companies that basically only function or or are reliant, upon one single geography is not something that we like to see these days, because, obviously, there has been a lot of volatility in very specific regions, in the last, whatever, twenty four months or so.
And therefore, the companies we invest into would like to see that those products and services basically cater to, at least in theory, a global customer base with b two b business models. As, Meredith mentioned beforehand, it's must be, must have products or services and not just nice to have ones.
And therefore you have very sticky customers, with recurring revenues. That's what we saw And that's what we like, like everyone does.
On the other hand, what we do have to be very flexible upon, and these companies also have to have the flexibility with their offerings, is that we can prioritize and deprioritize, markets very, very fast and very easily. So, concentration on one single geography, in terms of customer base, in terms of revenues, or also in terms of sourcing, of the supplies, is something we're trying to avoid, these days, with with the investments done.
But obviously very much focused. I mean, geography wise, the companies we invest into, they're all based in the DACH region, Nordics and Benelux.
And they're all in medtech pharma supplies, licensed tools, and the likes. So, which is still, though, a very big industry for these reasons.
Scott Voss
42:51 - 43:20
But but maybe just to clarify because for listeners that aren't as close to this, like, where HarborVest sits is kind of this global kind of diversified allocator. And when I talk about the importance of underwriting either the manager or the individual asset, that's where funds like Sasha and Marilyn's are the the the the ones that are doing the underwriting with a very specific focus.
They're part of the building blocks of the portfolios that we would build for our investors. Right?
Sascha Alilovic
43:20 - 43:59
Yeah. Yeah.
And I fully agree. I mean, I think, looking at the strategic asset allocation for your for your clients, basically.
I mean, that's not the essence that you balance the different geographies, different industries, different risk profiles, and so on. And that's where, well, at least, again, I'm biased.
I believe that someone who is specialized, comes into play because it basically, ticks the box, which needs to be ticked, potentially and and, is maybe a less a less cyclical than others. And and therefore, yeah, we we do have a bit of, let's say, the the application with that specific, so to speak, angle.
Scott Voss
43:59 - 44:01
Yep.
Marilyn Adler
44:01 - 45:01
And in the past, I had, just sort of. There's a big gap between what the company thinks they're worth and what a buyer is willing to pay.
So I've had a couple of portfolio companies go to market and then decide to, you know, back off, wait a year or two before they're gonna go. I'm hoping that, you know, some of the expectations come down a bit from, you know, from the company side, but every entrepreneur or owner managed business loves their company and thinks it's worth a lot.
And finding a buyer who's going to match that is, sometimes challenging, especially in this market. So I don't mind staying in longer with my I'm a debt.
I'm. I still.
My five year maturity is on mine. But, yeah, you.
On average, our our average life is about three years on our debt, but I just saw that there was definitely a gap in valuation expectations. So we'll see what happens for '27.
stefan rogalski
45:01 - 46:24
Absolutely. Yeah.
And, we're sort of moving into, the q and a session, and I think I'll sort of combine some questions with with, something else I wanted to touch on before we close, which is technology and, of course, AI. Right? And, at Intralinks, we're obviously close to how technology supports the deal making process, and we're seeing, an increase in adoption and deployment of AI across various workflows.
Right? And, you know, firms are looking to sort of work, smarter, move faster, get more value out of the information they're working with. And what's interesting to me is that everyone's still at, you know, different stages of their AI journey.
Right? Some are still evaluating where it makes sense to deploy and use AI, and others are already incorporating it into their day to day workflows, and investment processes. So, it does raise an interesting question about, AI where it's delivering value today and where it will be delivering value moving into into next year.
I'd love to get everyone's perspective on this. Marilyn, maybe we can start with you and, you know, perhaps where you're seeing technology and AI having, some impact, on the way you're looking at either evaluating opportunities or or managing portfolio or even deploying capital.
Marilyn Adler
46:24 - 47:51
Yep. We've been using Claude for our portfolio analysis as well as for screening deals.
And, really, it's just such a game changer for, the more junior people putting decks together, putting comps. I used to have to spend hours putting comps together.
You can get this information so much easier. And even across our portfolio, measuring, you know, margins across different portfolio companies in the same sectors.
Just this information is so much more available, and, a lot of our portfolio companies are starting to use AI in terms of, you know, processing and sales customers. I I just think that you still need to manage it, but it's, I don't know why anyone's not gonna be using AI for something as we move into this, into this stage.
So, I mean, someone told me that they're able to put a new deck that they get into AI, and it spits out a company name for you. So, you know, you have NDAs in place, but, like, here, anyone could figure out what the company is from AI.
So just kind of interesting. But, yeah, we've been using it now for everything, and it's really made a difference in terms of our being able to compare our industry, our whole industry analysis and getting that.
It's just been a lot easier.
stefan rogalski
47:51 - 47:58
Yeah. Scott, using a cloud user too, or are you exploring that sort of other other platforms?
Scott Voss
47:58 - 49:59
So we use Claude in in chat. You know, it's interesting though if you if you think about.
If I were to synthesize our AI journey, in a. In short form, you know, it kinda started with applications and tools that we're already using that then embedded AI in them.
So they were AI enabled, and that was kind of the easy part. That was the part that IT and compliance didn't have as hard of a time kinda getting their heads around.
And then it was the rollout of of Chad, GPT, and and Claw that took a little bit more kinda work. And and I think.
And and we're kind of in that phase where users are, you know, using the AI for their own kinda needs and applications. I wish there was, like, this this kinda all hands where, okay, let's all sit down and build our own chief of staff so we don't blow up our email when we try to do it on on our own.
And and I think that the direction that we're going is kind of the. What I call the AI harness, where you're kind of wrapping all of your processes and your technologies around your preferred LLM, and then it becomes this custom agent for how you actually run your your business.
And and I kind of alluded to this earlier. It's interesting, our PE managers, how they're approaching this almost parallel universe approach where they they rebuild the company using AI first mentality to replicate what the legacy company can do and then they figure out where they.
At what point do they converge and and merge together. You know, I I think we have a lot of users now, but they're all kinda using heavily, but probably not using the most efficiently.
But it's definitely automated our investment committee memo process, you know, as we download from Intralinks and kinda synthesize for our IR memos, everything that's in, in the data room. It's it's it's made.
I'd like to think it's made my associates job a little bit easier, although I think they're still burning the midnight oil right now.
stefan rogalski
49:59 - 50:02
Well, makes it easier so they can do more. But, Sasha,.
Scott Voss
50:02 - 50:05
Right. Right.
stefan rogalski
50:05 - 50:18
is, seeing similar things? Right? Is it is it sort of AI being used to make existing processes faster and more efficient, or are you seeing sorta. It's actually influencing investment decisions?
Sascha Alilovic
50:18 - 53:07
Well, for us, it's not influencing investment decisions so much, I would say. It's, everything that that, was, was said already, we're doing, I mean, in a very similar fashion, we're also using CheckTpT and Claude, and, and also as was mentioned before, we are all playing with it a bit.
We're all a bit, harmless beginners, on one hand. On the other hand, we can really see tremendous efficiency gains already.
And I'm wondering how this is going to look like in two years from today. But what's more important to me even is how we can actually help our portfolio companies.
And there it really changes the way, well, they operate, not only making it more efficient, but also more effective, to use an old phrasing, because, I mean, to give you an example, what I've found to be very, astonishing and exciting, use for example. We have a company that deploys.
Oh, it's basically always used when one of the big pharma companies, are country manufacturers, when they build a new site. You have to know early on when they build a new site, because then they can basically plan for that very specific, devices to be used as well.
It's ultra low temperature freezers. And it's something.
The later you get to know about someone planning for this, the worse it is for you because it's not made necessarily, thought of, built into a tender, for devices to be used and so on. And now we're using AI, an AI tool basically to scrape the internet for trying to find out when actually one of the big pharma companies in the world even bought a real estate in China, let's say for argument's sake, and figure out that, who is the right person is to be approached.
So that they know in two years time when they finally make the decision to actually, build a new building, that they have us in their minds on the products of this company, in the back of their minds to to consider when they actually draft the whole floor planning and what have you. So that's really, really changing and helping, on on that front and that element.
Well, we we are lucky enough that that in our in our, let's say, space, our industry, at least the segment, subsegment we are working in, AI is not really disrupting business models yet. It is rather, yeah, adding loads and tons of efficiency and adding new new ways of thinking it through, but they are not replaced by AI driven companies, I mean, for for a high number of reasons, but there's also a lot of devices, we obviously invest into on the on the, med tech side.
But then, yes, AI helps tremendously in making them more efficient, and so on.
stefan rogalski
53:07 - 53:40
Yeah. Great.
Great. Well, I'd like to finish with something a bit different.
We discussed a lot of different trends shaping the market, but I'm curious where each of you might see things differently from the broader market. Right? So what's, one widely held belief about private markets today that you disagree with? And what do you think the market is underestimating as we head into 2027? Start with Maryland.
Put you on the spot.
Marilyn Adler
53:40 - 55:21
there seems. It's okay.
There seems to be this widely held belief that, you know, private equity is struggling. You read in the journal about all these private equity firms that they're not gonna beat their returns and, you know, junior level people are leaving because their carry isn't gonna be worth anything.
But I I don't think that's true across all private equity firms. I feel like a lot of them are.
If you have. If they bought the asset in.
With a good pricing and can really create those efficiencies as you're growing these companies that they will realize value over time. I don't know if you saw.
I mean, it's just been a lot of bad press about private equity and returns being down, and that could be, but there's different vintage years. And, private credit itself is very differentiated.
There's the huge guys that don't wanna do anything below a 100,000,000 in size. And then I think in lower middle market credit as well as private equity, there's just a lot more opportunities in terms of being able to grow.
You know, you're able to buy in terms of pricing at a much lower price. Most of the add ons are getting done at four to six times EBITDA.
And then as you grow, you're hopefully being able to integrate these and making it a larger company and and really be able to realize some of these values. So I'm not down on private equity as much as, the papers Wall Street Journal has been coming up.
They had a bad article on New State the other day. I think there's a lot of private equity funds that are are gonna perform and do well.
So it's my projection.
stefan rogalski
55:21 - 55:25
Scott, what are your thoughts?
Scott Voss
55:25 - 57:19
Yeah. I'm probably in the in the same camp.
Like, in in. And it's along the lines of just don't always believe the headlines.
I I do think that what we're seeing in in private markets is they're bifurcating. So you.
If if you ask somebody, are you. Do you have a private market allocation and they say yes, I think your next question needs to be how do you have it? And with private markets functioning at the scale that they're functioning at, where buyouts can be done at 50,000,000,000 or greater, or you have IPOs of venture backed companies happening at a trillion or $2,000,000,000,000.
Those things tend to dominate the headlines, but they aren't what defines the broader industry. I I do think with this new investor we call wealth coming into the channel and the amount of capital that's coming in, it's a great opportunity for that investor.
But I think that part of the market is probably gonna look like an oligopoly where it's winners take most, and there are certain firms that are built to serve that part of the channel. But then, and this goes to me, how do you.
If you have a private market allocation, how do you have it? There's this other part of the market that institutions have been investing in forever that is constituted by thousands of firms. It's very much fragmented, and you can create alpha through finding managers that do their jobs really well.
And therefore, I think you have to look past that headline to really understand the truth of what's happening in the industry. And, and and I think that's incumbent on the industry to educate the the media and some newer investors who maybe aren't as familiar with the asset class to see beyond the headlines and and what's really, really happening.
So very much reaffirming kinda what what Marilyn has said.
Sascha Alilovic
57:19 - 58:32
Yeah. Maybe they just, I mean, a lot has been said, which I, which I can, which I can beg as well, but, I think we have been as an industry very much, well been on a hype for years and years and years for more than a decade.
Right. Which was a bit artificially inflated, based on, based on the low interest rates.
Now we have competition, so to speak, which is, just, just using investing into, into loans, fixed income, whatever. And you will have, a shakeout of the market, bifurcation as just mentioned.
But I think it's also actually not too bad for the industry because finally we were getting down to, we need to create value. We need to differentiate.
We need to prove to the world that, that we can, create alpha, and why we can create alpha. And what's.
I mean, there must be something we do different from others, and not just use leverage, basically. And and this is actually.
I mean, it's going to go through some brief tough years, but then this is going to be a completely normalized level again in in two, three years from now, I believe.
stefan rogalski
58:32 - 59:09
Well, that's that's great, and I think that's a a great place, to wrap up, and we are at time. We covered a lot of ground today.
It's been real. Really great hearing the different perspectives, and I wanna thank Marilyn, Scott, and Sasha for joining us today and sharing their insights.
We really appreciate your time. And, of course, thank you to everyone, who joined us.
If you'd like to explore some of the trends we discussed, in more detail, check out our 2026 Intralinks PE deal making report produced in collaboration with PitchBook. Thanks again, everyone, and enjoy the rest of your day.
Sascha Alilovic
59:09 - 59:10
Thanks.
Scott Voss
59:10 - 59:12
Yeah. Thank you.
Very well done.
Marilyn Adler
59:12 - 59:12
you so much.
Scott Voss
59:12 - 59:13
it.
Sascha Alilovic
59:13 - 59:14
for the invitation.